Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2021-06-10 4:09 pm Purchase | 13G | SCYNEXIS INC SCYX | HIRSCHMAN ORIN | 1,345,394 6.5% | 1,345,394 (New Position) | View |
| 2021-03-10 11:56 am Unchanged | 13G | SCYNEXIS INC SCYX | FEDERATED HERMES INC. FHI | 2,129,553 11.05% | 0 (Unchanged) | View |
| 2021-02-16 4:06 pm Purchase | 13G | SCYNEXIS INC SCYX | CAXTON CORP | 1,474,370 7.5% | 1,474,370 (New Position) | View |
| 2021-02-16 11:43 am Purchase | 13G | SCYNEXIS INC SCYX | Avidity Partners Management LP | 1,979,800 9.9% | 882,546 (+80.43%) | View |
| 2021-02-12 5:09 pm Sale | 13G | SCYNEXIS INC SCYX | Stonepine Capital Management LLC | 1,530,650 7.7% | -6,303 (-0.41%) | View |
| 2021-02-12 12:59 pm Sale | 13G | SCYNEXIS INC SCYX | FEDERATED HERMES INC. FHI | 2,129,553 19.47% | -16,480,859 (-88.56%) | View |
| 2021-02-11 10:59 am Purchase | 13G | SCYNEXIS INC SCYX | Puissance Life Science Opportunities Fund VI | 255,718 2.34% | 255,718 (New Position) | View |
| 2021-01-27 4:35 pm Purchase | 13G | SCYNEXIS INC SCYX | PERCEPTIVE ADVISORS LLC | 1,300,000 6.8% | 1,300,000 (New Position) | View |
| 2020-12-23 5:12 pm Purchase | 13G | SCYNEXIS INC SCYX | Stonepine Capital Management LLC | 1,536,953 7.7% | 1,536,953 (New Position) | View |
| 2020-12-23 4:15 pm Purchase | 13G | SCYNEXIS INC SCYX | Avidity Partners Management LP | 1,097,254 9.9% | 1,097,254 (New Position) | View |
| 2020-02-14 2:57 pm Purchase | 13G | SCYNEXIS INC SCYX | CAXTON CORP | 7,936,111 8.2% | 3,611,111 (+83.49%) | View |
| 2020-02-14 1:43 pm Purchase | 13G | SCYNEXIS INC SCYX | FEDERATED HERMES INC. FHI | 18,610,412 19.13% | 11,742,012 (+170.96%) | View |
| 2020-02-13 8:40 pm Sale | 13G | SCYNEXIS INC SCYX | Puissance Life Science Opportunities Fund VI | 126,865 0.002% | -4,882,965 (-97.47%) | View |
| 2019-12-23 4:07 pm Purchase | 13G | SCYNEXIS INC SCYX | Decheng Capital China Life Sciences USD Fund III L.P. | 5,555,556 5.8% | 5,555,556 (New Position) | View |
| 2019-12-20 4:13 pm Purchase | 13G | SCYNEXIS INC SCYX | ARMISTICE CAPITAL LLC | 6,222,778 5.7% | 6,222,778 (New Position) | View |